Each year, the UBC Faculty of Medicine recognizes outstanding faculty and staff who are dedicated to transforming health for everyone through innovative research, teaching excellence, and service to the University.…
Read More
Dr. Kurt Hoskin presented the IAMI Trial, which is an investigator-initiated, randomized, double-blind trial to compare inactivated influenza vaccine with saline placebo administered shortly after myocardial infarction or high-risk stable…
Read More
Dr. Gilbert Tang, Surgical Director of the Structural Heart Program at the Mount Sinai Health System, presented on the EXPLANT-TAVR International Registry.
Read More
Dr. Curtis Williams presented the TOMAHAWK Trial, which is a multicenter, randomized clinical trial comparing immediate coronary angiography to initial intensive care assessment with delayed or selective angiography among patients with successfully resuscitated out-of-hospital cardiac arrest of…
Read More
Dr. Charmaine Lam will presented the EMPEROR-Preserved Trial, which is a double-blind, randomized control trial comparing the use of empagliflozin (10mg) to placebo among patients with class II–IV heart failure…
Read More
Abstract Background: There remain major uncertainties regarding disease activity within the retained native aortic valve as well as bioprosthetic valve durability following transcatheter aortic valve implantation (TAVI). We aimed to assess…
Read More
Dr. Ian Pitcher presented the TTM2 Trial, which is an open-label trial with blinded assessment of outcomes comparing targeted hypothermia at 33°C, followed by controlled rewarming to targeted normothermia with…
Read More
Each year, the UBC Department of Medicine honours faculty and staff members who have made significant and meaningful contributions to education, teaching, research, mentorship, and administration. Our annual Awards Presentation…
Read More
Dr. Michael Thibert presented the RATE-AF Trial, which is a prospective, randomized, open-label, blinded, endpoint trial comparing the use of digoxin and beta-blockers as initial rate control therapy for permanent…
Read More
